ClinicalTrials.Veeva

Menu

The Efficacy and Complication of Gentamicin Nasal Irrigation in Chronic Rhinosinusitis and Recurrent Sinusitis

M

Mahidol University

Status and phase

Unknown
Phase 4

Conditions

Rhinosinusitis

Treatments

Drug: Normal saline nasal irrigation
Drug: Gentamicin nasal irrigation

Study type

Interventional

Funder types

Other

Identifiers

NCT02582099
271/2555(EC1)

Details and patient eligibility

About

Topical antibiotic therapy in patients with refractory sinusitis has been shown to improve symptoms, quality of life, and mucosal aspect. In pediatrics allergy clinic at Siriraj hospital since 2006 use Gentamicin nasal irrigation for chronic rhinosinusitis.There have been no prospective studies in gentamicin irrigation in chronic rhinosinusitis.

Full description

Chronic rhinosinusitis (CRS) is characterized by symptoms > 12 weeks.Two or more symptoms one of which should be either nasal blockage /obstruction/congestion or nasal discharge (anterior/posterior nasal drip): facial pain/pressure reduction or loss of smell).

Mainstay of treatment are medical and surgical treatment ( ATB, adenoidectomy, ESS) Adjunctive treatment : normal saline nasal irrigation, nasal corticosteroids, nasal decongestants, mucolytics. Nasal lavage with Mupirocin represent an effective and well tolerated alternative treatment of surgically recalcitrant chronic rhinosinusitis. Gentamicin irrigation should be helpful in chronic rhinosinusitis.

Enrollment

40 estimated patients

Sex

All

Ages

7 to 18 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Chronic rhinosinusitis and/or recurrent acute/subacute sinusitis patients who were followed in pediatrics allergy clinic at Siriraj hospital between December 4, 2012, and December 3, 2016

Exclusion criteria

  1. Patients who used antibiotic prophylaxis within within 1 year before and 6 months after started gentamicin nasal irrigation
  2. Patients received IVIG within 1 year before and 6 months after started gentamicin nasal irrigation
  3. Patients received IT within 1 year before and 6 months after started gentamicin nasal irrigation
  4. Patients underwent endoscopic sinus surgery within 1 year before and 6 months after started gentamicin nasal irrigation
  5. Patient who have mental retardation
  6. Patient who have aminoglycosides hypersensitivity reactions
  7. Pregnancy women and Lactation period
  8. Patient who have abnormal hearing test before started gentamicin nasal irrigation
  9. Patient who have chronic rhinosinusitis with nasal polyp

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

40 participants in 2 patient groups, including a placebo group

Gentamicin
Active Comparator group
Description:
Gentamicin nasal irrigation in chronic rhinosinusitis amount 20 ml each pernostril
Treatment:
Drug: Gentamicin nasal irrigation
Normal saline
Placebo Comparator group
Description:
Normal saline nasal irrigation in chronic rhinosinusitis amount 20 ml each pernostril
Treatment:
Drug: Normal saline nasal irrigation

Trial contacts and locations

1

Loading...

Central trial contact

Nualanong Visitsunthorn, Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems